Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

E Buy Home Inc (ID) EBYH

Strainsforpains, Inc. operates as a medical marijuana data recommendation system. The company develops Strainsforpains app, a user-based application that scientifically determines which cannabis brand or strain is right for patients based upon personal data and strain genetics. It serves medical specialists, dispensaries, and consumers. Strainsforpains, Inc. has a strategic partnership with GenBio, Inc. to license anti-inflammatory compounds in Strainsforpains CBD branded products. The company was incorporated in 1990 and is based in New York, New York.


OTCID:EBYH - Post by User

User Avatar Image
(5)
•••
  • CashSeekerX
Post by CashSeekeron May 14, 2024 9:14am
65 Views
Post# 36038410

$EBYH - CEO Discusses Entering 191 Billion Dollar Anti-Infl

$EBYH - CEO Discusses Entering 191 Billion Dollar Anti-Infl
 
$EBYH - Strainsforpains CEO Simon Shainberg Discusses Entering 191 Billion Dollar Anti-Inflammatory Market, and Strategic Partnership and Research Potential with GenBio Corp.
 
 
$EBYH - Strainsforpains CEO Simon Shainberg Discusses Entering 191 Billion Dollar Anti-Inflammatory Market, and Strategic Partnership and Research Potential with GenBio Corp.
 
 
<< Previous
Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities